Your browser doesn't support javascript.
loading
Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status.
Mi, Emma Z; Mi, Ella Z; di Pietro, Massimiliano; O'Donovan, Maria; Hardwick, Richard H; Richardson, Susan; Ziauddeen, Hisham; Fletcher, Paul C; Caldas, Carlos; Tischkowitz, Marc; Ragunath, Krish; Fitzgerald, Rebecca C.
Afiliación
  • Mi EZ; School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • Mi EZ; School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • di Pietro M; MRC Cancer Unit, Hutchison-MRC Research Centre, University of Cambridge, Cambridge, UK.
  • O'Donovan M; Department of Histopathology, Cambridge University Hospitals NHS Trust and University of Cambridge, Cambridge, UK.
  • Hardwick RH; Department of Oesophago-Gastric Surgery, Cambridge University Hospitals NHS Trust, Cambridge, UK.
  • Richardson S; Familial Gastric Cancer Study, Department of Oncology, Cambridge University Hospitals NHS Trust and University of Cambridge, Cambridge, UK.
  • Ziauddeen H; Cambridge and Peterborough NHS Foundation Trust, Cambridge, UK.
  • Fletcher PC; Department of Psychiatry, University of Cambridge, Cambridge, UK; Cambridge and Peterborough NHS Foundation Trust, Cambridge, UK.
  • Caldas C; Cancer Research UK Cambridge Institute, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Tischkowitz M; Department of Medical Genetics, University of Cambridge and Cambridge University Hospitals NHS Trust, Cambridge, UK.
  • Ragunath K; NIHR Nottingham Digestive Diseases Biomedical Research Unit, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Fitzgerald RC; MRC Cancer Unit, Hutchison-MRC Research Centre, University of Cambridge, Cambridge, UK.
Gastrointest Endosc ; 87(2): 408-418, 2018 02.
Article en En | MEDLINE | ID: mdl-28688938
ABSTRACT
BACKGROUND AND

AIMS:

Hereditary diffuse gastric cancer (HDGC) accounts for 1% of gastric cancer cases. For patients with a germline CDH1 mutation, risk-reducing gastrectomy is recommended. However, for those delaying surgery or for families with no causative mutation identified, regular endoscopy is advised. This study aimed to determine the yield of signet ring cell carcinoma (SRCC) foci in individuals with a CDH1 pathogenic variant compared with those without and how this varies with successive endoscopies.

METHODS:

Patients fulfilling HDGC criteria were recruited to a prospective longitudinal cohort study. Endoscopy was performed according to a strict protocol with visual inspection followed by focal lesion and random biopsy sampling to detect foci of SRCC. Survival analysis determined progression to finding of SRCC according to CDH1 mutation status. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 and 36-item Short Form Health Survey questionnaires assessed quality of life before surveillance and each endoscopy.

RESULTS:

Eighty-five individuals fulfilling HDGC criteria underwent 201 endoscopies; 54 (63.5%) tested positive for CDH1 mutation. SRCC yield was 61.1% in CDH1 mutation carriers compared with 9.7% in noncarriers, and mutation-positive patients had a 10-fold risk of SRCC on endoscopy compared with those with no mutation detected (P < .0005). Yield of SRCC decreased substantially with subsequent endoscopies. Surveillance was associated with improved psychological health.

CONCLUSIONS:

SRCC foci are prevalent in CDH1 mutation carriers and can be detected at endoscopy using a standardized, multiple biopsy sampling protocol. Decreasing yield over time suggests that the frequency of endoscopy might be reduced. For patients with no CDH1 pathogenic variant detected, the cost-to-benefit ratio needs to be assessed in view of the low yield.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Cadherinas / Vigilancia de la Población / Carcinoma de Células en Anillo de Sello Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Gastrointest Endosc Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Cadherinas / Vigilancia de la Población / Carcinoma de Células en Anillo de Sello Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Gastrointest Endosc Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido